{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-318078","form_type":"8-K","ticker":"KYMR","cik":"0001815442","company_name":"Kymera Therapeutics, Inc.","filed_at":"2026-07-27T20:10:37+00:00","discovered_at":"2026-07-27T20:11:00.271744+00:00","generated_at":"2026-07-27T20:11:09.220554+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Kymera Therapeutics appoints Terence Rooney as CMO; Jared Gollob retires","bullets":["Jared Gollob retired as CMO effective July 27, 2026; will remain as advisor through Dec 31, 2026.","Terence Rooney appointed CMO, previously SVP Portfolio & Asset Management Leader, Immunology at Johnson & Johnson.","Rooney also held senior immunology R&D roles at Eli Lilly and Roche; contributed to approvals of STELARA, TREMFYA, OLUMIANT.","Gollob's resignation is for personal reasons and not due to any disagreement with company policies."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-318078","json":"https://secwatch.observer/filing/0001193125-26-318078.json","markdown":"https://secwatch.observer/filing/0001193125-26-318078.md","text":"https://secwatch.observer/filing/0001193125-26-318078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526318078/0001193125-26-318078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526318078/d167778d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-27T20:11:09.220554+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}